# A bibliometric analysis of rapid-eye-movement sleep behavior disorder

**Authors:** Mingyue Liu, Xuqian Liu, Wenyan Liu, Dandan Tian, Bin Zheng, Yinfan Xiao, Jing Zhang, Feng Xu, Wei Shang, Zhaohong Xie

PMC · DOI: 10.3389/fneur.2026.1541715 · Frontiers in Neurology · 2026-02-13

## TL;DR

This paper uses bibliometric analysis to map the growth and key themes in research on rapid-eye-movement sleep behavior disorder (RBD) over 37 years.

## Contribution

It provides a comprehensive overview of RBD research trends, key institutions, and influential keywords using data from 4,229 publications.

## Key findings

- McGill University is the leading institution in RBD research.
- NEUROLOGY is the most cited journal in the field.
- Keywords like 'Parkinson’s disease' and 'rem sleep behavior disorder' are most common.

## Abstract

Rapid-eye-movement sleep behavior disorder(RBD) is a parasomnia characterized by the loss of normal muscle atonia during rapid eye movement (REM) sleep, leading individuals to physically act out vivid, often intense or violent dreams, which may result in self-injury or harm to others. In recent years, RBD has become a prominent research focus. The bibliometrics can clearly and intuitively display the research profile, relationships, and clustering within the field. This study examines the development of RBD research using bibliometric analysis. As of 18 January 2026, articles on RBD in the Web of Science Core Collection (WoSCC) were collected. CiteSpace is utilized to analyze and visualize the attributes of the articles, including number of publications, institution, journals, authors, keywords, from the 4,229 publications obtained. The leading institution in this field was McGill University, and the most cited journal was NEUROLOGY. The most common keywords were “Parkinson’s disease” and “rem sleep behavior disorder.” The study conducted a bibliometric analysis of over 37 years of RBD research, identifying the authors, institutions, keywords, journals, and publications involved in this field. The findings provide a comprehensive overview of RBD research.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Diseases:** neurological diseases (MESH:D020271), Multiple system atrophy (MESH:D019578), aggression (MESH:D010554), Dementia (MESH:D003704), NEUROLOGY (MESH:D009461), MSA (MESH:C537381), cognitive decline (MESH:D003072), REM sleep (MESH:D020187), neurodegeneration (MESH:D019636), REM (MESH:D020923), parasomnia (MESH:D020447), Sleep Disorders (MESH:D012893), PD (MESH:D010300), muscle atonia (MESH:D019042), narcolepsy type 1 (MESH:C563534), violent behaviors (MESH:D001523), Alzheimer's disease (MESH:D000544), LBDs (MESH:D020961), alpha-synucleinopathies (MESH:D000080874), XL (MESH:D000080345)
- **Chemicals:** melatonin (MESH:D008550), clonazepam (MESH:D002998), pramipexole (MESH:D000077487)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945786/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945786/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945786/full.md

---
Source: https://tomesphere.com/paper/PMC12945786